Shou‐Jiang Gao

发表

Molecular approaches to the identification of unculturable infectious agents.

P. Moore, S. Gao, Shou‐Jiang Gao, 1996, Emerging infectious diseases.

Kaposi's sarcoma-associated herpes virus disrupts adherens junctions and increases endothelial permeability by inducing degradation of VE-cadherin

W. Greene, Fengchun Ye, S. Gao, 2008, Journal of Virology.

Seroconversion to antibodies against Kaposi's sarcoma-associated herpesvirus-related latent nuclear antigens before the development of Kaposi's sarcoma.

J. Phair, R. Detels, L. Kingsley, 1996, The New England journal of medicine.

Antibodies to butyrate-inducible antigens of Kaposi's sarcoma-associated herpesvirus in patients with HIV-1 infection.

R. Sun, J. Levy, L. Heston, 1996, The New England journal of medicine.

Primary characterization of a herpesvirus agent associated with Kaposi's sarcomae

E. Cesarman, D. McGeoch, P. Pellett, 1996, Journal of virology.

The 222- to 234-kilodalton latent nuclear protein (LNA) of Kaposi's sarcoma-associated herpesvirus (human herpesvirus 8) is encoded by orf73 and is a component of the latency-associated nuclear antigen

L. Rainbow, T. Schulz, C. Herrington, 1997, Journal of virology.

Risk of Kaposi's sarcoma-associated herpes virus transmission from donor allografts among Italian posttransplant Kaposi's sarcoma patients.

M. Moroni, M. Corbellino, G. Sirchia, 1997, Blood.

Seroprevalence of Kaposi's sarcoma-associated herpesvirus infection among blood donors from Texas.

J. Baillargeon, H. Jenson, J. Alexander, 2001, Annals of epidemiology.

Kaposi’s Sarcoma-Associated Herpesvirus Infection Promotes Invasion of Primary Human Umbilical Vein Endothelial Cells by Inducing Matrix Metalloproteinases (cid:1)

J. Xie, Fengchun Ye, S. Gao, 2007 .